title: The primacy of CD8 T lymphocytes in type 1 diabetes and implications for therapies.
abstract: Type I diabetes (TID) is an autoimmune disease in which insulin-secreting beta cells of the pancreatic islets are destroyed by T lymphocytes. Until the 1990s, the prevailing dogma was that the attack was attributable to rogue T lymphocytes bearing CD4 markers on their surface (CD4 T helper lymphocytes). Today, the prevailing view is that rogue T cells bearing CD8 markers or cytotoxic CD8 T lymphocytes are also important and perhaps the foremost contributors to beta-cell death. Recognizing CD8 T-cell subsets as the prime culprits has helped to trace the disease's pathogenesis to abnormal T-cell education. Defective education can occur when antigen-presenting cells fail to assemble and present self-antigens to naïve T cells. The failure in that process, normally designed to prevent T cells' attack on the body's own antigens, enables self-reactive T cells to escape into the circulation. Once released, the self-reactive CD8 T cells kill specific self-antigens, which, in the case of TID, include insulin and other key proteins associated with beta cell functions. Abnormalities during T-cell education have been mapped in part to genetic defects in specific gene-encoding regions of the major histocompatibility complex class I region and to proteins that assemble self-peptides into the MHC class I structure that map within the MHC class II region. Two decades of research have led to understanding of genetic and functional defects in the immune system, placing us at the threshold of finding new therapeutic strategies aimed at eliminating autoreactive CD8 T cells, while preserving healthy immune cells.
authors.affiliation: Immunobiology Laboratory, Massachusetts General Hospital and Harvard Medical School, Charlestown, MA 02129, USA. faustman@helix.mgh.harvard.edu
authors.forename: Denise L
authors.initials: DL
authors.lastname: Faustman
authors.forename: Miriam
authors.initials: M
authors.lastname: Davis
mesh_terms: D000818:Animals; D001327:Autoimmune Diseases / Q000276:immunology / Q000503:physiopathology / Q000628:therapy; D015551:Autoimmunity; D018414:CD8-Positive T-Lymphocytes / Q000276:immunology* / Q000473:pathology*; D003922:Diabetes Mellitus, Type 1 / Q000276:immunology / Q000503:physiopathology / Q000628:therapy; D004195:Disease Models, Animal; D006801:Humans; D050417:Insulin-Secreting Cells / Q000276:immunology*; D051379:Mice; D016688:Mice, Inbred NOD
references.citation: N Engl J Med. 1993 Sep 30;329(14):977-86
references.pmid: 8366922
references.citation: J Clin Invest. 1993 May;91(5):2301-7
references.pmid: 8486790
references.citation: J Clin Invest. 2001 Jul;108(1):63-72
references.pmid: 11435458
references.citation: Proc Natl Acad Sci U S A. 2008 Sep 9;105(36):13644-9
references.pmid: 18755894
references.citation: Science. 2003 Nov 14;302(5648):1223-7
references.pmid: 14615542
references.citation: Tissue Antigens. 2003 Feb;61(2):146-53
references.pmid: 12694582
references.citation: Adv Immunol. 2008;100:1-12
references.pmid: 19111161
references.citation: J Immunol. 2003 Jan 1;170(1):620-7
references.pmid: 12496451
references.citation: Tissue Antigens. 1997 Dec;50(6):576-85
references.pmid: 9458110
references.citation: Genet Epidemiol. 1995;12(5):441-53
references.pmid: 8557177
references.citation: Cell. 1985 Sep;42(2):457-67
references.pmid: 2411422
references.citation: Science. 1991 Dec 20;254(5039):1756-61
references.pmid: 1763324
references.citation: Proc Natl Acad Sci U S A. 1991 Dec 15;88(24):11032-6
references.pmid: 1763019
references.citation: Diabetes Care. 2005 Oct;28(10):2384-7
references.pmid: 16186267
references.citation: Nature. 1991 Sep 26;353(6342):326-9
references.pmid: 1922338
references.citation: J Immunol. 1999 Jan 15;162(2):852-9
references.pmid: 9916708
references.citation: Diabetes. 2007 Jan;56(1):270-5
references.pmid: 17192492
references.citation: Ann Rheum Dis. 2006 Aug;65(8):1021-7
references.pmid: 16414974
references.citation: J Immunol. 1997 Sep 15;159(6):3068-80
references.pmid: 9300732
references.citation: Hum Immunol. 1997 Apr 1;53(2):159-66
references.pmid: 9129974
references.citation: Diabetes. 1988 Oct;37(10):1444-8
references.pmid: 2458291
references.citation: Nature. 1987 Oct 8-14;329(6139):506-12
references.pmid: 3309677
references.citation: Nat Med. 1999 Sep;5(9):1026-31
references.pmid: 10470079
references.citation: Nature. 1990 Nov 15;348(6298):213-6
references.pmid: 1700303
references.citation: Ann N Y Acad Sci. 1998 Apr 15;842:138-55
references.pmid: 9599304
references.citation: Hum Immunol. 2002 Aug;63(8):657-64
references.pmid: 12121673
references.citation: Proc Natl Acad Sci U S A. 1994 Nov 8;91(23):11128-32
references.pmid: 7972022
references.citation: Diabetes. 1993 Jan;42(1):44-55
references.pmid: 8093606
references.citation: Eur J Immunol. 1992 Sep;22(9):2387-93
references.pmid: 1516628
references.citation: J Immunol. 1989 Aug 15;143(4):1094-100
references.pmid: 2787356
references.citation: Nature. 1989 Dec 7;342(6250):692-6
references.pmid: 2594067